BioSpace News Archive

Genetown

Dyno Therapeutics Launches to Improve Viral Vectors for Gene Therapy

The technique allows the researchers to engineer the virus shell to deliver the gene package to the exact cell type in the body they intend to treat.

December 16, 2019
·
2 min read
·
Mark Terry
FDA

Amarin Snags Approval for Milestone Cardiovascular Risk Drug Vascepa

Vascepa capsules are the first-and-only prescription treatment approved by the FDA comprised solely of the active ingredient, icosapent ethyl, a unique form of eicosapentaenoic acid.

December 16, 2019
·
3 min read
·
Alex Keown
Policy

Opposition to Pelosi Drug Pricing Plan Remains Firm Following Passage in the House

The plan, put forth by House Speaker Nancy Pelosi, was passed last week on a mostly party-line vote, with support from two Republicans.

December 16, 2019
·
3 min read
·
Alex Keown
FDA

Avadel’s Nouress Approved for Total Parenteral Nutrition

Dublin-based Avadel Pharma announced that the U.S. Food and Drug Administration had approved its Nouress for neonatal patients requiring total parenteral nutrition.

December 16, 2019
·
2 min read
·
Mark Terry
Deals

Charles River Laboratories Moves into Cell Therapies with $380 Million Acquisition of HemaCare

Following a partnership with Bit Bio announced earlier this month, this morning, CRL announced the acquisition of HemaCare for approximately $380 million in cash.

December 16, 2019
·
2 min read
·
Alex Keown
Business

Top Priorities for Men When It Comes to Life Sciences Employers

According to the 2019 Ideal Employer Report, men’s #1 priority is interesting and meaningful work.

December 16, 2019
·
2 min read
·
Alex Keown
Policy

Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals

PERTH, AU, Dec 13, 2019 - - Holista CollTech announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system.

December 16, 2019
·
4 min read
Deals

CELLINK’s board has set financial targets for the company

CELLINK’s goal is to grow sales organically with a minimum of 35% per year and grow additionally through acquisitions.

December 16, 2019
·
1 min read
Policy

PharmaMar signs a new agreement with Megapharm to commercialize Yondelis® in Israel

PharmaMar shall receive an upfront payment and is eligible for additional remunerations, including regulatory milestone payments.

December 16, 2019
·
3 min read
Policy

Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Positive Opinion is based on data from the Phase 3 TITAN study which were published in The New England Journal of Medicine

December 16, 2019
·
9 min read